Aurobindo products in WHO list
Aurobindo Pharma Ltd on January 18, 2006 announced the inclusion of two of its anti-retroviral products, Nevirapine oral suspension 50 mg / 5 ml and Stavudine for oral solution 1 mg / ml, in World Health Organisation's pre-qualification list.
Both these products, which are used as a part of first line treatment in pediatric AIDS, have been included in the prequalification list for the first time, the pharma major informed the Stock Exchanges.
This inclusion takes the count of the company's products in the prequalification list to twelve, it added.
Aurobindo Pharma manufactures and exports bulk drugs, formulations, and oral suspensions.
(The Economic Times)